

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | tricarboxylic acid cycle (GO:0006099) | 6.24686804 |
| 2 | mannose metabolic process (GO:0006013) | 5.46749798 |
| 3 | fatty acid beta-oxidation (GO:0006635) | 5.24024600 |
| 4 | lysine metabolic process (GO:0006553) | 5.12547891 |
| 5 | lysine catabolic process (GO:0006554) | 5.12547891 |
| 6 | aspartate family amino acid catabolic process (GO:0009068) | 5.04613131 |
| 7 | GDP-mannose metabolic process (GO:0019673) | 4.98482478 |
| 8 | branched-chain amino acid catabolic process (GO:0009083) | 4.96265740 |
| 9 | carnitine shuttle (GO:0006853) | 4.95869743 |
| 10 | NADH metabolic process (GO:0006734) | 4.91845731 |
| 11 | valine metabolic process (GO:0006573) | 4.90293732 |
| 12 | 2-oxoglutarate metabolic process (GO:0006103) | 4.85406409 |
| 13 | fatty acid catabolic process (GO:0009062) | 4.63827186 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.62791688 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.62791688 |
| 16 | short-chain fatty acid metabolic process (GO:0046459) | 4.58466846 |
| 17 | succinate metabolic process (GO:0006105) | 4.55065444 |
| 18 | branched-chain amino acid metabolic process (GO:0009081) | 4.54034664 |
| 19 | fatty acid transmembrane transport (GO:1902001) | 4.53001548 |
| 20 | acetyl-CoA metabolic process (GO:0006084) | 4.52587766 |
| 21 | fatty acid oxidation (GO:0019395) | 4.50805278 |
| 22 | tricarboxylic acid metabolic process (GO:0072350) | 4.42741920 |
| 23 | lipid oxidation (GO:0034440) | 4.42319946 |
| 24 | L-phenylalanine catabolic process (GO:0006559) | 4.41508202 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.41508202 |
| 26 | negative regulation of cell size (GO:0045792) | 4.40826764 |
| 27 | carnitine metabolic process (GO:0009437) | 4.38955450 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.32833781 |
| 29 | biotin metabolic process (GO:0006768) | 4.30779597 |
| 30 | proline biosynthetic process (GO:0006561) | 4.28253908 |
| 31 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.23763626 |
| 32 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.23216927 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.17649154 |
| 34 | glyoxylate metabolic process (GO:0046487) | 4.15443985 |
| 35 | thioester biosynthetic process (GO:0035384) | 4.14076810 |
| 36 | acyl-CoA biosynthetic process (GO:0071616) | 4.14076810 |
| 37 | carnitine transmembrane transport (GO:1902603) | 4.13337992 |
| 38 | carnitine transport (GO:0015879) | 4.09563018 |
| 39 | amino-acid betaine transport (GO:0015838) | 4.09563018 |
| 40 | monocarboxylic acid catabolic process (GO:0072329) | 4.09308491 |
| 41 | amino-acid betaine metabolic process (GO:0006577) | 4.07995976 |
| 42 | respiratory electron transport chain (GO:0022904) | 4.07436243 |
| 43 | oxidative phosphorylation (GO:0006119) | 4.04753119 |
| 44 | oxaloacetate metabolic process (GO:0006107) | 4.04300598 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.01313601 |
| 46 | apoptotic process involved in morphogenesis (GO:0060561) | 3.99619043 |
| 47 | electron transport chain (GO:0022900) | 3.98879994 |
| 48 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.97875022 |
| 49 | quinone biosynthetic process (GO:1901663) | 3.95382974 |
| 50 | ubiquinone biosynthetic process (GO:0006744) | 3.95382974 |
| 51 | UV protection (GO:0009650) | 3.93015666 |
| 52 | sarcomere organization (GO:0045214) | 3.89159250 |
| 53 | snRNA metabolic process (GO:0016073) | 3.88698009 |
| 54 | response to misfolded protein (GO:0051788) | 3.85500452 |
| 55 | semaphorin-plexin signaling pathway (GO:0071526) | 3.84507257 |
| 56 | positive regulation of histone deacetylation (GO:0031065) | 3.83850270 |
| 57 | Golgi transport vesicle coating (GO:0048200) | 3.81771914 |
| 58 | COPI coating of Golgi vesicle (GO:0048205) | 3.81771914 |
| 59 | creatine metabolic process (GO:0006600) | 3.80260640 |
| 60 | regulation of fatty acid oxidation (GO:0046320) | 3.78154319 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 3.78051387 |
| 62 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.77592941 |
| 63 | thioester metabolic process (GO:0035383) | 3.74533986 |
| 64 | acyl-CoA metabolic process (GO:0006637) | 3.74533986 |
| 65 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.74054410 |
| 66 | ATP synthesis coupled proton transport (GO:0015986) | 3.74054410 |
| 67 | regulation of sequestering of triglyceride (GO:0010889) | 3.65337966 |
| 68 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 3.63763581 |
| 69 | protein retention in ER lumen (GO:0006621) | 3.62726199 |
| 70 | ethanol oxidation (GO:0006069) | 3.58939604 |
| 71 | snRNA processing (GO:0016180) | 3.57639554 |
| 72 | ubiquinone metabolic process (GO:0006743) | 3.55885024 |
| 73 | quaternary ammonium group transport (GO:0015697) | 3.54847020 |
| 74 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.54049509 |
| 75 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.48026443 |
| 76 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.48005201 |
| 77 | regulation of cholesterol metabolic process (GO:0090181) | 3.44147416 |
| 78 | regulation of triglyceride catabolic process (GO:0010896) | 3.43381296 |
| 79 | carboxylic acid catabolic process (GO:0046395) | 3.43275991 |
| 80 | organic acid catabolic process (GO:0016054) | 3.43275991 |
| 81 | response to mercury ion (GO:0046689) | 3.42634514 |
| 82 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.42476031 |
| 83 | ketone body metabolic process (GO:1902224) | 3.41990137 |
| 84 | sulfur amino acid catabolic process (GO:0000098) | 3.41522742 |
| 85 | protein insertion into membrane (GO:0051205) | 3.40628002 |
| 86 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.37729893 |
| 87 | proline metabolic process (GO:0006560) | 3.37100204 |
| 88 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.33788697 |
| 89 | cardiac myofibril assembly (GO:0055003) | 3.33687788 |
| 90 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.33072336 |
| 91 | glucose 6-phosphate metabolic process (GO:0051156) | 3.28956041 |
| 92 | regulation of cofactor metabolic process (GO:0051193) | 3.28845506 |
| 93 | regulation of coenzyme metabolic process (GO:0051196) | 3.28845506 |
| 94 | aromatic amino acid family catabolic process (GO:0009074) | 3.28515668 |
| 95 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.27124508 |
| 96 | positive regulation of protein deacetylation (GO:0090312) | 3.26696066 |
| 97 | alpha-amino acid catabolic process (GO:1901606) | 3.25514163 |
| 98 | cellular amino acid catabolic process (GO:0009063) | 3.25212776 |
| 99 | cysteine metabolic process (GO:0006534) | 3.23587782 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.23170228 |
| 101 | basement membrane organization (GO:0071711) | 3.22755544 |
| 102 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.21394091 |
| 103 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.18451103 |
| 104 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.17750433 |
| 105 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.16268714 |
| 106 | coenzyme catabolic process (GO:0009109) | 3.12852816 |
| 107 | coenzyme A metabolic process (GO:0015936) | 3.11326475 |
| 108 | positive regulation of fatty acid oxidation (GO:0046321) | 3.11250166 |
| 109 | cellular modified amino acid catabolic process (GO:0042219) | 3.10317912 |
| 110 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.08675510 |
| 111 | cardiac muscle contraction (GO:0060048) | 3.08011719 |
| 112 | dicarboxylic acid catabolic process (GO:0043649) | 3.08002131 |
| 113 | kynurenine metabolic process (GO:0070189) | 3.07942584 |
| 114 | regulation of ARF GTPase activity (GO:0032312) | 3.07311425 |
| 115 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.06218281 |
| 116 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.03972612 |
| 117 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.02402479 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 3.00991967 |
| 119 | urinary tract smooth muscle contraction (GO:0014848) | 3.00418417 |
| 120 | L-serine metabolic process (GO:0006563) | 2.99843302 |
| 121 | NIK/NF-kappaB signaling (GO:0038061) | 2.97867862 |
| 122 | myofibril assembly (GO:0030239) | 2.97496193 |
| 123 | cardiolipin metabolic process (GO:0032048) | 2.97090078 |
| 124 | positive regulation of vascular permeability (GO:0043117) | 2.96883089 |
| 125 | cell migration in hindbrain (GO:0021535) | 2.96276538 |
| 126 | gluconeogenesis (GO:0006094) | 2.95632986 |
| 127 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.95293918 |
| 128 | small molecule catabolic process (GO:0044282) | 2.94956141 |
| 129 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.94480495 |
| 130 | glycine metabolic process (GO:0006544) | 2.94411808 |
| 131 | aspartate family amino acid metabolic process (GO:0009066) | 2.93550571 |
| 132 | drug transmembrane transport (GO:0006855) | 2.92587824 |
| 133 | mitochondrial fusion (GO:0008053) | 2.92268039 |
| 134 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.90400555 |
| 135 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.90308432 |
| 136 | granulocyte differentiation (GO:0030851) | 2.89716638 |
| 137 | positive regulation of protein dephosphorylation (GO:0035307) | 2.89167352 |
| 138 | dicarboxylic acid metabolic process (GO:0043648) | 2.88931852 |
| 139 | atrioventricular valve morphogenesis (GO:0003181) | 2.88867448 |
| 140 | fatty acid homeostasis (GO:0055089) | 2.85923195 |
| 141 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.85723775 |
| 142 | protein maturation by protein folding (GO:0022417) | 2.85436279 |
| 143 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.83519385 |
| 144 | synaptic vesicle exocytosis (GO:0016079) | 2.80698521 |
| 145 | negative regulation of autophagy (GO:0010507) | 2.80397661 |
| 146 | adherens junction assembly (GO:0034333) | 2.79396931 |
| 147 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.78729782 |
| 148 | protein localization to endosome (GO:0036010) | 2.78601402 |
| 149 | urea cycle (GO:0000050) | 2.78455837 |
| 150 | peptidyl-arginine N-methylation (GO:0035246) | 2.78413739 |
| 151 | peptidyl-arginine methylation (GO:0018216) | 2.78413739 |
| 152 | positive regulation of synapse maturation (GO:0090129) | 2.78349421 |
| 153 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.77130479 |
| 154 | modulation by virus of host process (GO:0019054) | 2.72573355 |
| 155 | barbed-end actin filament capping (GO:0051016) | 2.71484025 |
| 156 | cell-cell junction maintenance (GO:0045217) | 2.71230772 |
| 157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.70689269 |
| 158 | retrograde transport, endosome to Golgi (GO:0042147) | 2.70234356 |
| 159 | positive regulation of action potential (GO:0045760) | 2.66896065 |
| 160 | mitotic nuclear envelope reassembly (GO:0007084) | 2.65400136 |
| 161 | nuclear envelope reassembly (GO:0031468) | 2.65400136 |
| 162 | activation of MAPKKK activity (GO:0000185) | 2.64823466 |
| 163 | adhesion of symbiont to host (GO:0044406) | 2.63716886 |
| 164 | erythrocyte maturation (GO:0043249) | 2.63240037 |
| 165 | urea metabolic process (GO:0019627) | 2.61052906 |
| 166 | cell-substrate adherens junction assembly (GO:0007045) | 2.60732183 |
| 167 | focal adhesion assembly (GO:0048041) | 2.60732183 |
| 168 | apoptotic process involved in development (GO:1902742) | 2.59708221 |
| 169 | activation of Rac GTPase activity (GO:0032863) | 2.58887995 |
| 170 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.57057281 |
| 171 | regulation of ARF protein signal transduction (GO:0032012) | 2.55837706 |
| 172 | folic acid metabolic process (GO:0046655) | 2.55831334 |
| 173 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.54346639 |
| 174 | negative regulation of viral release from host cell (GO:1902187) | 2.54128277 |
| 175 | behavioral response to pain (GO:0048266) | 2.54114653 |
| 176 | thymic T cell selection (GO:0045061) | 2.53138833 |
| 177 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.52803777 |
| 178 | ncRNA 3-end processing (GO:0043628) | 2.51406792 |
| 179 | amyloid precursor protein catabolic process (GO:0042987) | 2.50157044 |
| 180 | response to laminar fluid shear stress (GO:0034616) | 2.50150044 |
| 181 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48898119 |
| 182 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.47473588 |
| 183 | endothelial cell chemotaxis (GO:0035767) | 2.47081664 |
| 184 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.46877962 |
| 185 | modulation by symbiont of host cellular process (GO:0044068) | 2.46426696 |
| 186 | positive regulation of protein sumoylation (GO:0033235) | 2.45398307 |
| 187 | cell volume homeostasis (GO:0006884) | 2.45095631 |
| 188 | regulation of histone H3-K27 methylation (GO:0061085) | 2.44867504 |
| 189 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.43690875 |
| 190 | autophagic vacuole assembly (GO:0000045) | 2.43290376 |
| 191 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.42993371 |
| 192 | regulation of translational fidelity (GO:0006450) | 2.41845085 |
| 193 | regulation of macrophage chemotaxis (GO:0010758) | 2.41165139 |
| 194 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.38117458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.23956054 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.62546827 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17025957 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.02178673 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.58706268 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.51987226 |
| 7 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.31877471 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.02020766 |
| 9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80986479 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.67913111 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61086308 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.49542184 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.45003150 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.42443858 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.35301489 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23664390 |
| 17 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.22004606 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.18808504 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.16381085 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.06918893 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.05504945 |
| 22 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.94249925 |
| 23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.92090102 |
| 24 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.91705858 |
| 25 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.89555007 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75928881 |
| 27 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.73457316 |
| 28 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.71828465 |
| 29 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.66886398 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.66648651 |
| 31 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.65523336 |
| 32 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.65186191 |
| 33 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.64091543 |
| 34 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.61747963 |
| 35 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.61460301 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60757414 |
| 37 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.59924359 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59378862 |
| 39 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.57551715 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57491963 |
| 41 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.56808127 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.56779403 |
| 43 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.55349208 |
| 44 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.54960227 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.53684955 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52339449 |
| 47 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.52092188 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.49782250 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.47480865 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45122412 |
| 51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.44738435 |
| 52 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.44367031 |
| 53 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.44367031 |
| 54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44020151 |
| 55 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43967133 |
| 56 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43677389 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41822749 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41438170 |
| 59 | P68_20966046_ChIP-Seq_HELA_Human | 1.39293930 |
| 60 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.37077924 |
| 61 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32388984 |
| 62 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30341629 |
| 63 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.30004173 |
| 64 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.29888640 |
| 65 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29800589 |
| 66 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.29759663 |
| 67 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.29111851 |
| 68 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.28847153 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.28705615 |
| 70 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.27515306 |
| 71 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27495761 |
| 72 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.26417035 |
| 73 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.25597221 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25131564 |
| 75 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25074771 |
| 76 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24658302 |
| 77 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24247242 |
| 78 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.23701863 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.23183306 |
| 80 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.23161474 |
| 81 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21490724 |
| 82 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.21096291 |
| 83 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.20904204 |
| 84 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18521742 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18435736 |
| 86 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18059162 |
| 87 | * SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.18013373 |
| 88 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.17251923 |
| 89 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.16698449 |
| 90 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.16448709 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15662243 |
| 92 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.15087003 |
| 93 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14495346 |
| 94 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14275871 |
| 95 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.13629405 |
| 96 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12741294 |
| 97 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.12648746 |
| 98 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12197913 |
| 99 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12076520 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11791267 |
| 101 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11107729 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11008446 |
| 103 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10602410 |
| 104 | GATA1_19941826_ChIP-Seq_K562_Human | 1.09241155 |
| 105 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09031359 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.08395372 |
| 107 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.08365588 |
| 108 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08062661 |
| 109 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06570133 |
| 110 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.05824824 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 1.05700295 |
| 112 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.03854676 |
| 113 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03434508 |
| 114 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03308801 |
| 115 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.02216485 |
| 116 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01401804 |
| 117 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.01202533 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99364407 |
| 119 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98769617 |
| 120 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.98553961 |
| 121 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98448007 |
| 122 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.98260415 |
| 123 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98225250 |
| 124 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97282401 |
| 125 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.94521045 |
| 126 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94480194 |
| 127 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.93916020 |
| 128 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93479569 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.92984961 |
| 130 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92103082 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90251378 |
| 132 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90168673 |
| 133 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89864255 |
| 134 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.88476714 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.87864697 |
| 136 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.86780050 |
| 137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86102960 |
| 138 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85949022 |
| 139 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.85933482 |
| 140 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85884325 |
| 141 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84811051 |
| 142 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84256207 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.84117557 |
| 144 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.83654359 |
| 145 | P300_27268052_Chip-Seq_Bcells_Human | 0.83211639 |
| 146 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82395007 |
| 147 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.82277514 |
| 148 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.81637841 |
| 149 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81143338 |
| 150 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.80544339 |
| 151 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80211828 |
| 152 | SA1_27219007_Chip-Seq_Bcells_Human | 0.80116753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.71695415 |
| 2 | MP0003646_muscle_fatigue | 4.37537046 |
| 3 | MP0005360_urolithiasis | 3.93639051 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.89782393 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.66415583 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.48429591 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.34643865 |
| 8 | MP0000751_myopathy | 3.17947698 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 3.15507098 |
| 10 | MP0004084_abnormal_cardiac_muscle | 3.01932416 |
| 11 | MP0008260_abnormal_autophagy | 2.95183938 |
| 12 | MP0005365_abnormal_bile_salt | 2.92802960 |
| 13 | MP0009840_abnormal_foam_cell | 2.82632061 |
| 14 | MP0005330_cardiomyopathy | 2.80451999 |
| 15 | MP0006036_abnormal_mitochondrial_physio | 2.79018096 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.77195519 |
| 17 | MP0003172_abnormal_lysosome_physiology | 2.68889294 |
| 18 | MP0004858_abnormal_nervous_system | 2.64536093 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.62401518 |
| 20 | MP0005332_abnormal_amino_acid | 2.50099932 |
| 21 | MP0004130_abnormal_muscle_cell | 2.48704182 |
| 22 | MP0004147_increased_porphyrin_level | 2.46630597 |
| 23 | MP0009278_abnormal_bone_marrow | 2.44372477 |
| 24 | MP0005076_abnormal_cell_differentiation | 2.44344001 |
| 25 | MP0000749_muscle_degeneration | 2.39541935 |
| 26 | MP0010329_abnormal_lipoprotein_level | 2.26818055 |
| 27 | MP0005670_abnormal_white_adipose | 2.22587042 |
| 28 | MP0008438_abnormal_cutaneous_collagen | 2.03519377 |
| 29 | MP0004087_abnormal_muscle_fiber | 2.00136403 |
| 30 | MP0005666_abnormal_adipose_tissue | 1.97061585 |
| 31 | MP0004859_abnormal_synaptic_plasticity | 1.90027185 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.88041186 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.86280273 |
| 34 | MP0002269_muscular_atrophy | 1.86212036 |
| 35 | MP0005083_abnormal_biliary_tract | 1.85802103 |
| 36 | MP0003137_abnormal_impulse_conducting | 1.84232028 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.83838536 |
| 38 | MP0001849_ear_inflammation | 1.80684964 |
| 39 | MP0008775_abnormal_heart_ventricle | 1.80393410 |
| 40 | MP0003656_abnormal_erythrocyte_physiolo | 1.80096471 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.78252910 |
| 42 | MP0003279_aneurysm | 1.77580769 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.76608764 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.76392244 |
| 45 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.76283415 |
| 46 | MP0004043_abnormal_pH_regulation | 1.71299782 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.67488895 |
| 48 | MP0003436_decreased_susceptibility_to | 1.64147257 |
| 49 | MP0001958_emphysema | 1.62459641 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.60817400 |
| 51 | MP0004947_skin_inflammation | 1.59644262 |
| 52 | MP0001544_abnormal_cardiovascular_syste | 1.59035469 |
| 53 | MP0005385_cardiovascular_system_phenoty | 1.59035469 |
| 54 | MP0001661_extended_life_span | 1.58774431 |
| 55 | MP0010630_abnormal_cardiac_muscle | 1.56528116 |
| 56 | MP0000747_muscle_weakness | 1.55454787 |
| 57 | MP0005266_abnormal_metabolism | 1.53291358 |
| 58 | MP0002971_abnormal_brown_adipose | 1.44097769 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.43600255 |
| 60 | MP0005501_abnormal_skin_physiology | 1.42811618 |
| 61 | MP0003186_abnormal_redox_activity | 1.40661765 |
| 62 | MP0005171_absent_coat_pigmentation | 1.40269296 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.40003388 |
| 64 | MP0005451_abnormal_body_composition | 1.37037710 |
| 65 | MP0002106_abnormal_muscle_physiology | 1.36659757 |
| 66 | MP0006138_congestive_heart_failure | 1.36381665 |
| 67 | MP0001666_abnormal_nutrient_absorption | 1.34680433 |
| 68 | MP0005257_abnormal_intraocular_pressure | 1.33474321 |
| 69 | MP0004510_myositis | 1.32855217 |
| 70 | MP0006035_abnormal_mitochondrial_morpho | 1.31258331 |
| 71 | MP0002249_abnormal_larynx_morphology | 1.30794856 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.28789029 |
| 73 | MP0001764_abnormal_homeostasis | 1.27807629 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.25122715 |
| 75 | MP0004085_abnormal_heartbeat | 1.24793780 |
| 76 | MP0000681_abnormal_thyroid_gland | 1.24587306 |
| 77 | MP0000609_abnormal_liver_physiology | 1.23685832 |
| 78 | MP0002933_joint_inflammation | 1.23588157 |
| 79 | MP0001968_abnormal_touch/_nociception | 1.21731457 |
| 80 | MP0000462_abnormal_digestive_system | 1.20986931 |
| 81 | MP0003091_abnormal_cell_migration | 1.18864070 |
| 82 | MP0000759_abnormal_skeletal_muscle | 1.18265072 |
| 83 | MP0003252_abnormal_bile_duct | 1.17902064 |
| 84 | MP0004233_abnormal_muscle_weight | 1.14656263 |
| 85 | MP0003195_calcinosis | 1.14401321 |
| 86 | MP0002796_impaired_skin_barrier | 1.13377130 |
| 87 | MP0003329_amyloid_beta_deposits | 1.13265948 |
| 88 | MP0005535_abnormal_body_temperature | 1.12565626 |
| 89 | MP0000858_altered_metastatic_potential | 1.12469150 |
| 90 | MP0009931_abnormal_skin_appearance | 1.12204970 |
| 91 | MP0005310_abnormal_salivary_gland | 1.11841314 |
| 92 | MP0001873_stomach_inflammation | 1.11558357 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 1.10714855 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 1.09218090 |
| 95 | MP0005409_darkened_coat_color | 1.08843619 |
| 96 | MP0000750_abnormal_muscle_regeneration | 1.06602123 |
| 97 | MP0002089_abnormal_postnatal_growth/wei | 1.06209943 |
| 98 | MP0002396_abnormal_hematopoietic_system | 1.05586027 |
| 99 | MP0009384_cardiac_valve_regurgitation | 1.04999367 |
| 100 | MP0005397_hematopoietic_system_phenotyp | 1.02521732 |
| 101 | MP0001545_abnormal_hematopoietic_system | 1.02521732 |
| 102 | MP0005369_muscle_phenotype | 1.02383877 |
| 103 | MP0001529_abnormal_vocalization | 1.01968380 |
| 104 | MP0003879_abnormal_hair_cell | 1.00783959 |
| 105 | MP0002332_abnormal_exercise_endurance | 1.00150333 |
| 106 | MP0003634_abnormal_glial_cell | 0.97334464 |
| 107 | MP0002970_abnormal_white_adipose | 0.95234301 |
| 108 | MP0002735_abnormal_chemical_nociception | 0.92909807 |
| 109 | MP0010771_integument_phenotype | 0.92185351 |
| 110 | MP0002736_abnormal_nociception_after | 0.91748759 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.90391934 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.88705696 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.87621734 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.87591005 |
| 115 | MP0003959_abnormal_lean_body | 0.87467957 |
| 116 | MP0004270_analgesia | 0.87141617 |
| 117 | MP0008874_decreased_physiological_sensi | 0.85689630 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.85648842 |
| 119 | MP0001502_abnormal_circadian_rhythm | 0.85628033 |
| 120 | MP0004484_altered_response_of | 0.85249890 |
| 121 | MP0005621_abnormal_cell_physiology | 0.84307741 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.83640132 |
| 123 | MP0001216_abnormal_epidermal_layer | 0.81852884 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.81712401 |
| 125 | MP0005334_abnormal_fat_pad | 0.81524666 |
| 126 | MP0002127_abnormal_cardiovascular_syste | 0.80377103 |
| 127 | MP0003111_abnormal_nucleus_morphology | 0.80000167 |
| 128 | MP0000920_abnormal_myelination | 0.79622294 |
| 129 | MP0003690_abnormal_glial_cell | 0.79166582 |
| 130 | MP0003950_abnormal_plasma_membrane | 0.77402129 |
| 131 | MP0000358_abnormal_cell_content/ | 0.77277333 |
| 132 | MP0004381_abnormal_hair_follicle | 0.76681879 |
| 133 | MP0004145_abnormal_muscle_electrophysio | 0.76609981 |
| 134 | MP0002098_abnormal_vibrissa_morphology | 0.75889358 |
| 135 | MP0003303_peritoneal_inflammation | 0.75839183 |
| 136 | MP0005448_abnormal_energy_balance | 0.75361831 |
| 137 | MP0000733_abnormal_muscle_development | 0.74746225 |
| 138 | MP0003283_abnormal_digestive_organ | 0.74588997 |
| 139 | MP0005636_abnormal_mineral_homeostasis | 0.74328672 |
| 140 | MP0005452_abnormal_adipose_tissue | 0.71994492 |
| 141 | MP0002822_catalepsy | 0.71951089 |
| 142 | MP0002060_abnormal_skin_morphology | 0.70499638 |
| 143 | MP0002909_abnormal_adrenal_gland | 0.70190044 |
| 144 | MP0005058_abnormal_lysosome_morphology | 0.69470882 |
| 145 | MP0009697_abnormal_copulation | 0.69334122 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.68390020 |
| 147 | MP0008872_abnormal_physiological_respon | 0.66581994 |
| 148 | MP0000767_abnormal_smooth_muscle | 0.66084231 |
| 149 | MP0000598_abnormal_liver_morphology | 0.65770629 |
| 150 | MP0001243_abnormal_dermal_layer | 0.64736371 |
| 151 | MP0009115_abnormal_fat_cell | 0.63648928 |
| 152 | MP0001348_abnormal_lacrimal_gland | 0.63392892 |
| 153 | MP0005023_abnormal_wound_healing | 0.63050458 |
| 154 | MP0000604_amyloidosis | 0.62855006 |
| 155 | MP0001730_embryonic_growth_arrest | 0.61976775 |
| 156 | MP0009642_abnormal_blood_homeostasis | 0.61804192 |
| 157 | MP0004742_abnormal_vestibular_system | 0.58878497 |
| 158 | MP0005384_cellular_phenotype | 0.58421052 |
| 159 | MP0003075_altered_response_to | 0.57653046 |
| 160 | MP0000685_abnormal_immune_system | 0.57038561 |
| 161 | MP0003011_delayed_dark_adaptation | 0.56316494 |
| 162 | MP0000266_abnormal_heart_morphology | 0.56188840 |
| 163 | MP0005165_increased_susceptibility_to | 0.56008747 |
| 164 | MP0000367_abnormal_coat/_hair | 0.55629680 |
| 165 | MP0004019_abnormal_vitamin_homeostasis | 0.55458125 |
| 166 | MP0001756_abnormal_urination | 0.54689239 |
| 167 | MP0000013_abnormal_adipose_tissue | 0.53553429 |
| 168 | MP0003868_abnormal_feces_composition | 0.51721345 |
| 169 | MP0003953_abnormal_hormone_level | 0.51253400 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myoglobinuria (HP:0002913) | 4.73719032 |
| 2 | Hepatic necrosis (HP:0002605) | 4.69013011 |
| 3 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.48355257 |
| 4 | Dicarboxylic aciduria (HP:0003215) | 4.29374986 |
| 5 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.29374986 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.29312733 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.17530277 |
| 8 | Ketosis (HP:0001946) | 4.16949546 |
| 9 | Hyperammonemia (HP:0001987) | 4.05952285 |
| 10 | Hyperglycinuria (HP:0003108) | 4.03187870 |
| 11 | Increased muscle lipid content (HP:0009058) | 4.03084011 |
| 12 | Ketoacidosis (HP:0001993) | 4.01128086 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.84130607 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84130607 |
| 15 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.80471495 |
| 16 | Acute encephalopathy (HP:0006846) | 3.78013423 |
| 17 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.75511867 |
| 18 | Sudden death (HP:0001699) | 3.75478347 |
| 19 | Rhabdomyolysis (HP:0003201) | 3.74300843 |
| 20 | Exercise-induced muscle cramps (HP:0003710) | 3.69924028 |
| 21 | Increased serum pyruvate (HP:0003542) | 3.63221251 |
| 22 | Abnormality of glycolysis (HP:0004366) | 3.63221251 |
| 23 | Hyperacusis (HP:0010780) | 3.61802650 |
| 24 | Cerebral edema (HP:0002181) | 3.60931104 |
| 25 | Exercise-induced myalgia (HP:0003738) | 3.55273368 |
| 26 | Broad face (HP:0000283) | 3.53973634 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 3.51731362 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 3.48467944 |
| 29 | Ragged-red muscle fibers (HP:0003200) | 3.44753298 |
| 30 | Increased CSF lactate (HP:0002490) | 3.43754618 |
| 31 | Mitochondrial inheritance (HP:0001427) | 3.43164158 |
| 32 | Ulnar bowing (HP:0003031) | 3.36242411 |
| 33 | Vertebral compression fractures (HP:0002953) | 3.29658721 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.27747392 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 3.26874679 |
| 36 | Upper limb amyotrophy (HP:0009129) | 3.26874679 |
| 37 | Thin bony cortex (HP:0002753) | 3.21581320 |
| 38 | Lactic acidosis (HP:0003128) | 3.20223389 |
| 39 | Testicular atrophy (HP:0000029) | 3.18171614 |
| 40 | J-shaped sella turcica (HP:0002680) | 3.17254018 |
| 41 | Palpitations (HP:0001962) | 3.16023167 |
| 42 | Lipid accumulation in hepatocytes (HP:0006561) | 3.10644185 |
| 43 | Lethargy (HP:0001254) | 3.08877942 |
| 44 | Ventricular tachycardia (HP:0004756) | 3.07512115 |
| 45 | Generalized aminoaciduria (HP:0002909) | 3.00939778 |
| 46 | Increased cerebral lipofuscin (HP:0011813) | 3.00869365 |
| 47 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98558505 |
| 48 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98558505 |
| 49 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98558505 |
| 50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.93582923 |
| 51 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.93582923 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.93582923 |
| 53 | Xanthomatosis (HP:0000991) | 2.92338593 |
| 54 | Stridor (HP:0010307) | 2.91216660 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88917333 |
| 56 | Hyperglycinemia (HP:0002154) | 2.87660494 |
| 57 | Calf muscle hypertrophy (HP:0008981) | 2.81564942 |
| 58 | Respiratory failure (HP:0002878) | 2.77565111 |
| 59 | Methylmalonic aciduria (HP:0012120) | 2.77121042 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.75891550 |
| 61 | Progressive macrocephaly (HP:0004481) | 2.75885327 |
| 62 | Cervical subluxation (HP:0003308) | 2.74469781 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.73551367 |
| 64 | Metabolic acidosis (HP:0001942) | 2.73523708 |
| 65 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.72104496 |
| 66 | Reticulocytosis (HP:0001923) | 2.72003376 |
| 67 | Cerebral aneurysm (HP:0004944) | 2.69676971 |
| 68 | Hand muscle atrophy (HP:0009130) | 2.68956110 |
| 69 | Dilated cardiomyopathy (HP:0001644) | 2.66702335 |
| 70 | Obstructive sleep apnea (HP:0002870) | 2.66628138 |
| 71 | Increased serum lactate (HP:0002151) | 2.65805537 |
| 72 | Lipoatrophy (HP:0100578) | 2.65139076 |
| 73 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.65119649 |
| 74 | Mucopolysacchariduria (HP:0008155) | 2.65119649 |
| 75 | CNS demyelination (HP:0007305) | 2.63251212 |
| 76 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.61591462 |
| 77 | Protrusio acetabuli (HP:0003179) | 2.61558717 |
| 78 | Exercise intolerance (HP:0003546) | 2.61282720 |
| 79 | Myopathic facies (HP:0002058) | 2.59593755 |
| 80 | Delayed CNS myelination (HP:0002188) | 2.59556678 |
| 81 | Muscle fiber splitting (HP:0003555) | 2.58793775 |
| 82 | Neuroendocrine neoplasm (HP:0100634) | 2.57006466 |
| 83 | Increased hepatocellular lipid droplets (HP:0006565) | 2.56144630 |
| 84 | Cholelithiasis (HP:0001081) | 2.55505522 |
| 85 | Annular pancreas (HP:0001734) | 2.53510834 |
| 86 | Glycosuria (HP:0003076) | 2.53346099 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.53346099 |
| 88 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.52950485 |
| 89 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.52950485 |
| 90 | Mesangial abnormality (HP:0001966) | 2.50175450 |
| 91 | Vomiting (HP:0002013) | 2.49869869 |
| 92 | Proximal tubulopathy (HP:0000114) | 2.45751871 |
| 93 | Atrial fibrillation (HP:0005110) | 2.44973006 |
| 94 | Gout (HP:0001997) | 2.44844622 |
| 95 | Insomnia (HP:0100785) | 2.43729528 |
| 96 | Intrahepatic cholestasis (HP:0001406) | 2.41916558 |
| 97 | Pheochromocytoma (HP:0002666) | 2.41513181 |
| 98 | Supraventricular tachycardia (HP:0004755) | 2.39284584 |
| 99 | Progressive muscle weakness (HP:0003323) | 2.38107340 |
| 100 | Biconcave vertebral bodies (HP:0004586) | 2.36502537 |
| 101 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.36426809 |
| 102 | Truncus arteriosus (HP:0001660) | 2.36321531 |
| 103 | Abnormal gallbladder morphology (HP:0012437) | 2.35861879 |
| 104 | Atrioventricular block (HP:0001678) | 2.35285452 |
| 105 | Primary atrial arrhythmia (HP:0001692) | 2.35063459 |
| 106 | Methylmalonic acidemia (HP:0002912) | 2.34240412 |
| 107 | Joint stiffness (HP:0001387) | 2.32446115 |
| 108 | Supraventricular arrhythmia (HP:0005115) | 2.31731373 |
| 109 | Deep venous thrombosis (HP:0002625) | 2.31278651 |
| 110 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.29065723 |
| 111 | Nausea (HP:0002018) | 2.28535835 |
| 112 | Nonimmune hydrops fetalis (HP:0001790) | 2.27080432 |
| 113 | Hypobetalipoproteinemia (HP:0003563) | 2.25319156 |
| 114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.24909909 |
| 115 | Osteolytic defects of the hand bones (HP:0009699) | 2.24909909 |
| 116 | Conjunctival hamartoma (HP:0100780) | 2.23522491 |
| 117 | Natal tooth (HP:0000695) | 2.22615064 |
| 118 | Premature rupture of membranes (HP:0001788) | 2.21963837 |
| 119 | Distal lower limb amyotrophy (HP:0008944) | 2.21932904 |
| 120 | Emotional lability (HP:0000712) | 2.21510694 |
| 121 | Ventricular arrhythmia (HP:0004308) | 2.19358567 |
| 122 | Ankle clonus (HP:0011448) | 2.18669064 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 2.18545688 |
| 124 | Hemorrhage of the eye (HP:0011885) | 2.18071303 |
| 125 | Cholecystitis (HP:0001082) | 2.17974147 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 2.17974147 |
| 127 | Supranuclear gaze palsy (HP:0000605) | 2.17080757 |
| 128 | Long palpebral fissure (HP:0000637) | 2.14465729 |
| 129 | Abnormality of serum amino acid levels (HP:0003112) | 2.13958184 |
| 130 | Turricephaly (HP:0000262) | 2.13915150 |
| 131 | Brushfield spots (HP:0001088) | 2.13214083 |
| 132 | Leukodystrophy (HP:0002415) | 2.12688789 |
| 133 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09967546 |
| 134 | Achilles tendon contracture (HP:0001771) | 2.09471862 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 2.06746934 |
| 136 | Wormian bones (HP:0002645) | 2.06246148 |
| 137 | Prolonged QT interval (HP:0001657) | 2.05440425 |
| 138 | Hypolipoproteinemia (HP:0010981) | 2.04444008 |
| 139 | Abnormality of the calf musculature (HP:0001430) | 2.04100087 |
| 140 | Syncope (HP:0001279) | 2.03895373 |
| 141 | Hyporeflexia of lower limbs (HP:0002600) | 2.03302037 |
| 142 | Subaortic stenosis (HP:0001682) | 2.03250273 |
| 143 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.03250273 |
| 144 | Late onset (HP:0003584) | 2.02405040 |
| 145 | Renal Fanconi syndrome (HP:0001994) | 2.02296514 |
| 146 | Muscle stiffness (HP:0003552) | 2.02072099 |
| 147 | Heart block (HP:0012722) | 2.02016227 |
| 148 | Distal lower limb muscle weakness (HP:0009053) | 2.00991785 |
| 149 | Difficulty running (HP:0009046) | 2.00666397 |
| 150 | Spastic paraparesis (HP:0002313) | 1.99604673 |
| 151 | Hypoglycemic seizures (HP:0002173) | 1.99500793 |
| 152 | Gastrointestinal dysmotility (HP:0002579) | 1.99476948 |
| 153 | Broad distal phalanx of finger (HP:0009836) | 1.99339991 |
| 154 | Loss of speech (HP:0002371) | 1.95721601 |
| 155 | Colitis (HP:0002583) | 1.95267045 |
| 156 | Shallow orbits (HP:0000586) | 1.95139516 |
| 157 | Pointed chin (HP:0000307) | 1.94078406 |
| 158 | Slow saccadic eye movements (HP:0000514) | 1.93241977 |
| 159 | Difficulty climbing stairs (HP:0003551) | 1.92600703 |
| 160 | Abnormality of the gallbladder (HP:0005264) | 1.91982414 |
| 161 | Easy fatigability (HP:0003388) | 1.90767043 |
| 162 | Increased connective tissue (HP:0009025) | 1.90494054 |
| 163 | Bowel incontinence (HP:0002607) | 1.90415834 |
| 164 | Advanced eruption of teeth (HP:0006288) | 1.89636891 |
| 165 | Poikiloderma (HP:0001029) | 1.88805740 |
| 166 | Abnormal cortical bone morphology (HP:0003103) | 1.88580643 |
| 167 | Dysmetric saccades (HP:0000641) | 1.87854110 |
| 168 | Atelectasis (HP:0100750) | 1.87047197 |
| 169 | Microvesicular hepatic steatosis (HP:0001414) | 1.86152858 |
| 170 | Cerebral inclusion bodies (HP:0100314) | 1.85378267 |
| 171 | Amblyopia (HP:0000646) | 1.83487740 |
| 172 | Disproportionate tall stature (HP:0001519) | 1.82685717 |
| 173 | Hypertriglyceridemia (HP:0002155) | 1.81529792 |
| 174 | Mitral regurgitation (HP:0001653) | 1.80225566 |
| 175 | Thin ribs (HP:0000883) | 1.79724931 |
| 176 | Neurofibrillary tangles (HP:0002185) | 1.79354577 |
| 177 | Abnormality of the Achilles tendon (HP:0005109) | 1.79343124 |
| 178 | Genu recurvatum (HP:0002816) | 1.78436508 |
| 179 | Abnormal large intestine physiology (HP:0012700) | 1.78373586 |
| 180 | Fragile skin (HP:0001030) | 1.76841449 |
| 181 | Hyperparathyroidism (HP:0000843) | 1.76134429 |
| 182 | Hypertensive crisis (HP:0100735) | 1.76071575 |
| 183 | Abnormality of the aortic arch (HP:0012303) | 1.75700350 |
| 184 | Visual hallucinations (HP:0002367) | 1.74161804 |
| 185 | Bulbar palsy (HP:0001283) | 1.71518709 |
| 186 | Autoamputation (HP:0001218) | 1.71018660 |
| 187 | Bladder diverticulum (HP:0000015) | 1.68810590 |
| 188 | Abnormality of the thoracic spine (HP:0100711) | 1.68554956 |
| 189 | Axonal loss (HP:0003447) | 1.68387726 |
| 190 | Peripheral hypomyelination (HP:0007182) | 1.68215519 |
| 191 | Spinal rigidity (HP:0003306) | 1.68096398 |
| 192 | Generalized amyotrophy (HP:0003700) | 1.67625758 |
| 193 | Elbow flexion contracture (HP:0002987) | 1.66543968 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.12583452 |
| 2 | SMG1 | 4.11142737 |
| 3 | LMTK2 | 4.09380362 |
| 4 | TRIB3 | 3.87064341 |
| 5 | PDK3 | 3.46511503 |
| 6 | PDK4 | 3.46511503 |
| 7 | PKN2 | 3.03504597 |
| 8 | PHKG1 | 2.92609281 |
| 9 | PHKG2 | 2.92609281 |
| 10 | PRPF4B | 2.85758442 |
| 11 | TTN | 2.50637877 |
| 12 | NEK1 | 2.46050928 |
| 13 | WNK4 | 2.43772870 |
| 14 | OBSCN | 2.41530044 |
| 15 | STK39 | 2.38722622 |
| 16 | IRAK3 | 2.23267671 |
| 17 | BRSK2 | 1.95675033 |
| 18 | CDK12 | 1.83670170 |
| 19 | BRSK1 | 1.76372722 |
| 20 | MYLK | 1.74923623 |
| 21 | MUSK | 1.72184413 |
| 22 | PINK1 | 1.69294837 |
| 23 | EPHB1 | 1.69189254 |
| 24 | TESK1 | 1.58310895 |
| 25 | ARAF | 1.58291359 |
| 26 | PRKD2 | 1.53778931 |
| 27 | ICK | 1.52538279 |
| 28 | SIK2 | 1.52181878 |
| 29 | SIK1 | 1.51645340 |
| 30 | MAP3K11 | 1.37319812 |
| 31 | MARK2 | 1.36616475 |
| 32 | PRKD3 | 1.36342455 |
| 33 | OXSR1 | 1.32190818 |
| 34 | PDK2 | 1.29940295 |
| 35 | ILK | 1.18353608 |
| 36 | TAOK2 | 1.14526916 |
| 37 | TAOK1 | 1.06844041 |
| 38 | MAP3K7 | 1.06241413 |
| 39 | CDK4 | 1.05663778 |
| 40 | NME1 | 1.04832175 |
| 41 | EPHA2 | 1.03705646 |
| 42 | FLT3 | 1.02776946 |
| 43 | CAMKK1 | 0.99800576 |
| 44 | VRK2 | 0.99100764 |
| 45 | BMX | 0.97166328 |
| 46 | MTOR | 0.95723504 |
| 47 | MAP3K10 | 0.94468001 |
| 48 | TNK2 | 0.92486981 |
| 49 | TIE1 | 0.89767820 |
| 50 | RPS6KA2 | 0.89557546 |
| 51 | CAMK1D | 0.89388107 |
| 52 | LRRK2 | 0.85774523 |
| 53 | KDR | 0.85541885 |
| 54 | MST1R | 0.84949973 |
| 55 | CDK19 | 0.84023127 |
| 56 | MET | 0.83382785 |
| 57 | CDC42BPA | 0.82828993 |
| 58 | BUB1 | 0.82742726 |
| 59 | PRKD1 | 0.82095573 |
| 60 | MAPK11 | 0.81527155 |
| 61 | TBK1 | 0.79259240 |
| 62 | BRAF | 0.79193342 |
| 63 | WNK1 | 0.78742528 |
| 64 | RIPK1 | 0.76891066 |
| 65 | PRKAA2 | 0.76203723 |
| 66 | PIM2 | 0.76150349 |
| 67 | PTK2 | 0.75868042 |
| 68 | PDPK1 | 0.75206572 |
| 69 | PBK | 0.75175053 |
| 70 | CAMK2D | 0.73862631 |
| 71 | PIK3CA | 0.73578611 |
| 72 | PAK4 | 0.72561928 |
| 73 | RAF1 | 0.70854908 |
| 74 | DMPK | 0.69969424 |
| 75 | PRKAA1 | 0.68990256 |
| 76 | AURKA | 0.68872670 |
| 77 | NME2 | 0.68531170 |
| 78 | PTK6 | 0.68049255 |
| 79 | EEF2K | 0.68038778 |
| 80 | TYK2 | 0.66795637 |
| 81 | CAMK2G | 0.66258881 |
| 82 | WEE1 | 0.65877720 |
| 83 | JAK3 | 0.62807333 |
| 84 | GRK6 | 0.62270798 |
| 85 | MAPKAPK3 | 0.62174948 |
| 86 | MAP4K1 | 0.62049053 |
| 87 | DAPK3 | 0.61031520 |
| 88 | MAPK12 | 0.60860775 |
| 89 | PAK3 | 0.58446836 |
| 90 | PDK1 | 0.57671440 |
| 91 | MAP2K2 | 0.57260442 |
| 92 | TYRO3 | 0.55393837 |
| 93 | ZAP70 | 0.51393175 |
| 94 | KSR2 | 0.51077124 |
| 95 | ERN1 | 0.50952233 |
| 96 | MAP3K13 | 0.50515979 |
| 97 | MAP2K3 | 0.50509159 |
| 98 | STK38 | 0.49134888 |
| 99 | NEK9 | 0.48987731 |
| 100 | CAMK4 | 0.48606052 |
| 101 | NTRK1 | 0.48518077 |
| 102 | WNK3 | 0.48477755 |
| 103 | PRKACG | 0.47777862 |
| 104 | STK24 | 0.46882489 |
| 105 | ABL2 | 0.46879751 |
| 106 | PRKACB | 0.46283612 |
| 107 | MAP3K3 | 0.45905673 |
| 108 | MAPK15 | 0.45633689 |
| 109 | PAK6 | 0.45595211 |
| 110 | MAP3K1 | 0.45392431 |
| 111 | PKN1 | 0.45367475 |
| 112 | SGK494 | 0.45036199 |
| 113 | SGK223 | 0.45036199 |
| 114 | MAP3K8 | 0.44830345 |
| 115 | CDK8 | 0.43229403 |
| 116 | RPS6KA6 | 0.43130610 |
| 117 | PDGFRA | 0.41012546 |
| 118 | TESK2 | 0.39808591 |
| 119 | DAPK1 | 0.39789210 |
| 120 | PAK1 | 0.39080857 |
| 121 | CAMK1 | 0.38463090 |
| 122 | RIPK4 | 0.37607262 |
| 123 | HIPK2 | 0.37472014 |
| 124 | AKT2 | 0.37414151 |
| 125 | PRKG2 | 0.37168206 |
| 126 | RPS6KC1 | 0.36700017 |
| 127 | RPS6KL1 | 0.36700017 |
| 128 | MAP3K6 | 0.35850526 |
| 129 | FES | 0.35464237 |
| 130 | ROCK2 | 0.35402381 |
| 131 | PIK3CG | 0.35246378 |
| 132 | MAPKAPK5 | 0.35240208 |
| 133 | MAP2K1 | 0.34645359 |
| 134 | CSNK1A1L | 0.34267631 |
| 135 | MAPK4 | 0.34207519 |
| 136 | LIMK1 | 0.34097240 |
| 137 | TTK | 0.34029704 |
| 138 | RPS6KA1 | 0.33712428 |
| 139 | PRKACA | 0.32305300 |
| 140 | UHMK1 | 0.32097194 |
| 141 | FGFR4 | 0.31281355 |
| 142 | MAP2K6 | 0.30121875 |
| 143 | CCNB1 | 0.29658191 |
| 144 | BLK | 0.29329107 |
| 145 | EPHA4 | 0.29254718 |
| 146 | RET | 0.29166429 |
| 147 | PRKCH | 0.28633585 |
| 148 | CAMK1G | 0.28571391 |
| 149 | PRKCQ | 0.27765092 |
| 150 | RPS6KB2 | 0.26787904 |
| 151 | CSNK1G3 | 0.26786220 |
| 152 | JAK2 | 0.25561841 |
| 153 | CAMK2B | 0.25173806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.21784743 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.74789032 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.61555423 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.59869062 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.40291811 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.26466074 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.21331583 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.90042378 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.85126388 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50621647 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.48980376 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43747502 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42079849 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.40034879 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.35378285 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.32695937 |
| 17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.24549843 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.14452690 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.13217446 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.04457288 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.99871678 |
| 22 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.98236078 |
| 23 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.95571536 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.93312360 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89520106 |
| 26 | Lysosome_Homo sapiens_hsa04142 | 1.86555280 |
| 27 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.81381523 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.79906774 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.79737352 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.75692815 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70955285 |
| 32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.69233746 |
| 33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.65038643 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60770509 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.51241171 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.48573800 |
| 37 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.46245499 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45523699 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44770222 |
| 40 | Prion diseases_Homo sapiens_hsa05020 | 1.39647462 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.38866194 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.34228791 |
| 43 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33528274 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.31146445 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 1.31073619 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28076290 |
| 47 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.28056396 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 1.26813650 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.24861886 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23492955 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.22837133 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22409678 |
| 53 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.12580238 |
| 54 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.12194265 |
| 55 | Huntingtons disease_Homo sapiens_hsa05016 | 1.09512910 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08716085 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.07771227 |
| 58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.06670589 |
| 59 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06648601 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.06279268 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.05424368 |
| 62 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.03225611 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.02782409 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.02093434 |
| 65 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.01499543 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.00362874 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00082246 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.99509938 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97480339 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95675180 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93273051 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92613442 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92470671 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.90090715 |
| 75 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.88137911 |
| 76 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.87389372 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86884009 |
| 78 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.86051408 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85336817 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85273227 |
| 81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84479666 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.84043125 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.83458306 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80675102 |
| 85 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79718448 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.77266768 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.76554534 |
| 88 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75431116 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75366476 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.74931899 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74343159 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73828373 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73589209 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.72832550 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.72740198 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71778830 |
| 97 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71005846 |
| 98 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69845900 |
| 99 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68964654 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68929660 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67673268 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.67487095 |
| 103 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66719163 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.66692431 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62775518 |
| 106 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62460503 |
| 107 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.62059529 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60835327 |
| 109 | * ABC transporters_Homo sapiens_hsa02010 | 0.60537342 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60171119 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59675247 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.59453177 |
| 113 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.58928427 |
| 114 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57797586 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57501429 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56969075 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56218700 |
| 118 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54279751 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53785302 |
| 120 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52483873 |
| 121 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51447934 |
| 122 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51440952 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50980534 |
| 124 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50808384 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50776703 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.50492324 |
| 127 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48171659 |
| 128 | Tuberculosis_Homo sapiens_hsa05152 | 0.46081205 |
| 129 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45539227 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.45106988 |
| 131 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.44118928 |
| 132 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43375879 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43064653 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41444845 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.39888437 |
| 136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39781354 |
| 137 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39372021 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38920133 |
| 139 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.38282597 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37128791 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.36930943 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36623485 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35982847 |
| 144 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.34875884 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34525203 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.34434534 |
| 147 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33369470 |
| 148 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32320728 |
| 149 | Insulin resistance_Homo sapiens_hsa04931 | 0.31392799 |
| 150 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27423124 |
| 151 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25006845 |
| 152 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24615469 |
| 153 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.19673281 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18019571 |
| 155 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.15703232 |
| 156 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.13880509 |
| 157 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.13588951 |
| 158 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12665429 |
| 159 | Ribosome_Homo sapiens_hsa03010 | 0.11102849 |
| 160 | DNA replication_Homo sapiens_hsa03030 | 0.09197686 |
| 161 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.06206089 |
| 162 | Purine metabolism_Homo sapiens_hsa00230 | 0.04733149 |
| 163 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.03877949 |
| 164 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.03219906 |
| 165 | Base excision repair_Homo sapiens_hsa03410 | -0.0481246 |
| 166 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0378140 |
| 167 | Proteasome_Homo sapiens_hsa03050 | -0.0126137 |

